| 2024-11-05 |
Acquired bla(CfxA-3) carried by a conjugative transposon or duplicated intrinsic bla(CME-3) mediates cefiderocol resistance in Elizabethkingia anophelis clinical isolates |
International Journal of Antimicrobial Agents. 2024 Nov 05;Article in Press. |
 |
| 2024-08-06 |
Changing epidemiology and antimicrobial resistance of bacteria causing bacteremia in Taiwan: 2002-2020 |
Microbiology Spectrum. 2024 Aug 6;12(8):Article number e0060824. |
|
| 2024-08 |
Imipenem reduces the efficacy of vancomycin against Elizabethkingia species |
Journal of Antimicrobial Chemotherapy. 2024 Aug 1;79(8):2048-2052. |
|
| 2024-07-10 |
Clonal expansion of Tn1546-like transposon-carrying vancomycin-resistant Enterococcus faecium, a nationwide study in Taiwan, 2004-2018 |
Journal of Global Antimicrobial Resistance. 2024 Jul 10;39:100-108. |
|
| 2024-07 |
The individual contributions of blaB, blaGOB and blaCME on MICs of Beta-lactams in Elizabethkingia anophelis |
Journal of Antimicrobial Chemotherapy. 2024 Jul;79(7):1577-1580. |
|
| 2024-01 |
In vitro and in vivo evidence discourages routine testing and reporting of piperacillin/tazobactam susceptibility of Elizabethkingia species |
Journal of Antimicrobial Chemotherapy. 2024 Jan 3;79(1):200-202 |
|
| 2023-11-28 |
Elizabethkingia anophelis outer membrane vesicles as a novel vaccine candidate against infection: Insights into immune response and potential for passive immunity |
mSphere. 2023 Nov 28;Article number e0040023. |
|
| 2023-08 |
High-level levofloxacin-resistant emm12 group A Streptococcus, 2012–2018: A multicenter study in Taiwan |
Journal of Microbiology, Immunology and Infection. 2023 Aug;56(4):875-879. |
|
| 2022-11 |
Contribution of testing strategies and contact tracing towards COVID-19 outbreaks control: A mathematical modeling study |
Tropical Medicine and Infectious Disease. 2022 Nov;7(11):Article number 376. |
|
| 2022-09-16 |
Biofilm formation is not an independent risk factor for mortality in patients with Acinetobacter baumannii bacteremia |
Frontiers in Cellular and Infection Microbiology. 2022 Sep 16;12:Article number 964539. |
|
| 2022-05-25 |
A comprehensive evaluation of COVID-19 policies and outcomes in 50 countries and territories |
Scientific Reports. 2022 May 25;12:Article number 8802. |
|
| 2022-05-16 |
Discrimination of methicillin-resistant staphylococcus aureus by MALDI-TOF mass spectrometry with machine learning techniques in patients with staphylococcus aureus bacteremia |
Pathogens. 2022 May 16;11(5):Article number 586. |
|
| 2022-05-01 |
In vitro and in vivo comparison of eravacycline- and tigecycline-based combination therapies for tigecycline-resistant Acinetobacter baumannii |
Journal of Chemotherapy. 2022 May 01;34(3):166-172. |
|
| 2022-04 |
The prediction values of carbapenemase detection methods and carbapenem susceptibility testing for clinical outcomes of patients with Acinetobacter bacteremia under carbapenem treatment |
Journal of Microbiology, Immunology and Infection. 2022 Apr;55(2):257-265. |
|
| 2021-08-06 |
In vitro activity of imipenem/relebactam, meropenem/vaborbactam, ceftazidime/avibactam, cefepime/zidebactam and other novel antibiotics against imipenem-non-susceptible Gram-negative bacilli from Taiwan |
Journal of Antimicrobial Chemotherapy. 2021 Aug 6;76(8):2071-2078. |
|
| 2021-08 |
Mobile resistomes of human pathogens in swine wastewater treatment plants |
Journal of Microbiology, Immunology, and Infection. 2021 Aug;54(4):752-754. |
|
| 2021-06-14 |
Antimicrobial resistance mechanisms and virulence of colistin-and carbapenem-resistant acinetobacter baumannii isolated from a teaching hospital in Taiwan |
Microorganisms. 2021 Jun 14;9(6):Article number 1295. |
|
| 2021-04-13 |
Multicentre study of risk factors for mortality in patients with acinetobacter bacteraemia receiving colistin treatment[Erratum:International Journal of Antimicrobial Agents. 2020 Jun;55(6):Article number 105956.] |
International Journal of Antimicrobial Agents. 2021 Apr 13;57(5):Article number 106333. |
 |
| 2021-03 |
Susceptibility of Elizabethkingia spp. to commonly tested and novel antibiotics and concordance between broth microdilution and automated testing methods |
Journal of Antimicrobial Chemotherapy. 2021 Mar;76(3):653-658. |
|
| 2021-02 |
Emergence of mcr-1, mcr-3, and mcr-8 in clinical Klebsiella pneumoniae isolates in Taiwan |
Clinical Microbiology and Infection. 2021 Feb;27(2):305-307. |
|
| 2021-02 |
In vitro and in vivo activities of imipenem combined with BLI-489 against class D Beta-lactamase-producing Acinetobacter baumannii |
Journal of Antimicrobial Chemotherapy. 2021 Feb;76(2):451-459. |
|
| 2021-02 |
Clinical and molecular characterization of Acinetobacter seifertii in Taiwan |
Journal of Antimicrobial Chemotherapy. 2021 Feb;76(2):312-321. |
|
| 2021-01 |
Nonpolio enterovirus activity during the COVID-19 pandemic, Taiwan, 2020 |
Emerging Infectious Diseases. 2021 Jan;27(1):306-308. |
|
| 2021-01 |
Ser253Leu substitution in PmrB contributes to colistin resistance in clinical Acinetobacter nosocomialis |
Emerging Microbes and Infections. 2021 Jan;10(1):1873-1880. |
|
| 2020-11-26 |
Clinical and economic impact of intensive care unit-acquired bloodstream infections in Taiwan: A nationwide population-based retrospective cohort study |
BMJ Open. 2020 Nov 26;10(11):Article number e037484. |
|
